Will Private Equity’s Bull-Rush Into Ophthalmology Drive Growth?

Bull Rushing with man hanging on.

Will private equity’s bull-rush into ophthalmology drive growth? Dick Lindstrom, MD addresses this notion in a podcast he did with Tom Salemi from OIS. Stated investment reasons by doctors (MDs) are access to capital and business expertise. Profit growth, cost reduction, and services aggregation are success drivers for private equity (PE) that I’ve heard. Will these two forces play well together today and in the future? To create growing enterprise value, I believe PE and their MD partners will wrestle seven market forces. These trends tie back to the increasing commercial cast to Ophthalmology. In the new order, some MDs … Read More

Private Equity, Ophthalmology and the Rise of the Mega Eye Practice

Private Equity has an Eye on Ophthalmology

Only time will tell if private equity can fuel growth in ophthalmology. Are Dick Lindstrom and his partners at Minnesota Eye Consultants (MEC) the tipping point for the spread of the Mega Practice? Is this right for our industry? Private Equity Let’s start with a definition of private equity. Investopedia defines private equity this way: “Private equity is capital that is not noted on a public exchange. Private equity is composed of funds and investors that directly invest in private companies, or that engage in buyouts of public companies, resulting in the delisting of public equity.” MEC partnered with Waud … Read More